[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615585":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":46,"collaborators":20,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":20,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":56,"minAge":57,"maxAge":20,"enrollmentInfo":58,"targetDuration":20,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Pak Emirates Military Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"PRF group","EXPERIMENTAL","Enrolled patients with chronic leg ulcers who will be administered PRF gel",[13],"Biological: Platelet rich Fibrin (PRF)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","Platelet rich Fibrin (PRF)","PRF is derived solely from the patient's own blood and does not contain any non-autologous additives, such as anticoagulants or bovine thrombin, as first-generation platelet concentrates (like some forms of PRP)",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Prof. Moizza Tahir, MBBS, FCPS, FRCP","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Ahsan Tameez Ud Din, MBBS","CONTACT","(+92 051) 9273480","ahsantameezuddinmalik@gmail.com",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":20,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Rawalpindi","Punjab Province","Pakistan","PK",{"type":39,"coordinates":40},"Point",[41,42],73.0479,33.59733,{"lat":42,"lon":41},[45],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},{"type":24,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Dr. Ahsan Tameez-ud-din","Registrar Dermatology","100615585","early-phase-1-efficacy-of-platelet-rich-fibrin-gel-in-patients-with-chronic-leg-ulcers-100615585",false,"NCT07294521","Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers","Inclusion Criteria:\n\n* All male and female patients more than 35 years old with Chronic Leg Ulcers, presenting to the OPD will be included.\n\nExclusion Criteria:\n\n* Patients with clinical signs of infected ulcers, patients in sepsis and immunosuppressed individuals will be excluded.",true,"ALL","35 Years",{"count":59,"type":60},40,"ESTIMATED","INTERVENTIONAL",[63],"EARLY_PHASE1","Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions. The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.",[66],"Chronic Leg Ulcer",[68,69],"Chronic leg ulcer","Platelet rich fibrin","2026-03-09",{"date":72,"type":73},"2026-03-11","ACTUAL",{"date":75,"type":73},"2025-12-16",{"date":77,"type":60},"2026-05-12",{"name":5,"class":6},1]